AstraZeneca Sells Former Blockbuster Cholesterol Drug For $320 Million

AstraZeneca said on Tuesday it would sell rights to its erstwhile blockbuster cholesterol drug, Crestor, to German pharmaceutical company Gruenenthal GmbH for an upfront payment of $320 million as the British drugmaker focuses on its cancer treatments portfolio.

from Top Business News- News18.com https://ift.tt/3qoAq9x

• Tweet
• Share
• Share
• Share
• Share